| |
Software Requirements
Microsoft Internet Explorer 5.01 or higher and Netscape Navigator 4.75 or higher are recommended. |
|
 |
J.Health Sci., 53(2), 240-244, 2007
Capsaicin, A Ligand for Vanilloid Receptor-1, Transduces Suppressive Signal for Osteoclast Differentiation in Bone
Morichika Takita, Masaki Inada,
and Chisato Miyaura*
Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan
Vanilloid receptor-1 (VR1) has been reported to exhibit multiple functions which can transduce painsensitive signals in nerve systems. A VR1 ligand, capsaicin, has been reported to show activities against inflammation and cancer growth, however, its role in bone metabolism is still unknown. Here, we examined the effect of capsaicin on cytokine-induced inflammatory bone resorption. Capsaicin suppressed interleukin-1-induced bone resorption in a mouse calvarial organ ex vivo culture in a dose-dependent manner. An assay using cocultures of osteoblasts and bone marrow cells clearly showed the inhibition of osteoclast formation by treatment with capsaicin. Receptor activator of NF-κB ligand (RANKL), the sole inducer of osteoclast formation, is known to be produced by osteoblasts. In the cocultures of bone marrow cells and osteoblasts, the expression of RANKL was suppressed by capsaicin. VR1 showed expression predominantly in osteoblasts, suggesting that capsaicin directly modulates osteoclast differentiation through the suppression of RANKL expression. VR1 ligands like capsaicin have the potential for use as clinical drugs targeting some bone diseases involving cytokine-induced bone resorption.
|
|
